-
Nidhi Sahni, PhD,
MD Anderson Cancer Center
Early Career Investigator Grant
Systems Approach for PARP-based Novel Combination Therapy in Ovarian Cancer
-
David Chapel, MD,
Brigham and Women’s Hospital
Mentored Investigator Grant
The Migratory Precursor and Serous Carcinogenesis
-
Yilun Deng, PhD,
University of Texas Health Science Center at San Antonio
Mentored Investigator Grant
CD122-Selective IL-2 Complexes as Novel Ovarian Cancer Therapy
-
James Duncan, PhD,
Fox Chase Cancer Center
Early Career Investigator Grant
Exploring PROTAC-Mediated Degradation of BRD4 in Ovarian Cancer
-
Mark Eckert, PhD,
University of Chicago
Early Career Investigator Grant
The Fate and Function of Adipocytes in Ovarian Cancer Metastasis
-
Sudipto Ganguly, PhD,
Johns Hopkins University
Early Career Investigator Grant
Characterizing a Novel Checkpoint Axis in High-Grade Serous Ovarian Cancer
-
Brooke Howitt, MD,
Stanford University
Early Career Investigator Grant
Identifying the Cell of Origin for Ovarian High-Grade Serous Carcinoma
-
Elizabeth Lee, MD,
Dana Farber Cancer Institute
Mentored Investigator Grant
Phase II Trial of Gemcitabine+ATR Inhibitor: Translational Studies
-
Jianhuang Lin, PhD,
The Wistar Institute
Mentored Investigator Grant
Targeting ER Stress Pathway in CARM1-Expressing Ovarian Cancer
-
Duygu Ozmadenci, PhD,
University of California - San Diego
Mentored Investigator Grant
Sensitizing Ovarian Cancer to Immunotherapies
-
Sunila Pradeep, PhD,
Medical College of Wisconsin
Early Career Investigator Grant
Epigenetic Causes of Acquired Resistance of Anti-VEGF Therapy
-
Elizabeth Raupach, PhD,
The Translational Genomics Research Institute
Mentored Investigator Grant
Oncogenic Consequences of Altered SWI/SNF-RNA Interactions in SCCOHT
-
Camilla Salvagno, PhD,
Weill Medical College of Cornell University
Mentored Investigator Grant
Dissecting How ER Stress Responses Shape Ovarian Cancer Immuno-Environments
-
Janice Santiago, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Crizotinib Improves the Therapeutic Efficacy of Olaparib in Ovarian Cancer
-
Ignacio Vázquez-García, PhD,
Memorial Sloan Kettering Cancer Center
Mentored Investigator Grant
Co-Evolution and Dynamics of Malignant and Immune Cells in Ovarian Cancer
-
Boris Winterhoff, MD,
University of Minnesota Twin Cities
Early Career Investigator Grant
Precision Medicine in Ovarian Cancer: Using Single Cell Analysis
-
Morozov Yaroslav, PhD,
University of Pennsylvania
Mentored Investigator Grant
The BRCA1-A as a Determinant of Chemotherapy Response in ATM Mutated Cells
-
Dmitriy Zamarin, MD, PhD,
Memorial Sloan Kettering Cancer Center
Early Career Investigator Grant
Chromatin Remodeling and Immunotherapy in Ovarian Cancer
-
Andrew K. Godwin, PhD,
University of Kansas Medical Center Research Institute
Collaborative Research Development Grant
Tumor-Derived Extracellular Vesicle in Ovarian Cancer
-
Sohrab Shah, PhD,
Memorial Sloan Kettering Cancer Center
Collaborative Research Development Grant
Profiling Co-Evolution of Ovarian Cancer and its Immune Microenvironment
-
Ugo Cavallaro, PhD,
Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Fondazione Monzino
Collaborative Research Development Grant
Interplay Between Ovarian Cancer Stem Cells and the Tumor Microenvironment
-
Sandra Orsulic, PhD,
UCLA School of Medicine
Collaborative Research Development Grant
Co-Evolution of Epithelial Ovarian Cancer and Tumor Stroma